DEI/Health Equity
1
Date of Presentation
5-2-2024 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
As the prevalence of chronic pain rises, the number of patients prescribed opioids is increasing. Consequently, the rate of opioid overdose has increased, becoming a public health concern.For these reasons, the Center for Disease Control and Prevention recommended co-prescribing naloxone, a medicine that reverses the effects of opioid overdose.While this medication can be lifesaving, it is not accessible or available to everyone in need of it. A systematic review of existing literature pertaining to the barriers in patients receiving naloxone was conducted to evaluate the major obstacles in patients receiving a naloxone co-prescription. The results show that the major deterrents include financial cost, geographic location, education, and stigma. Based on these findings, it is recommended that more trainings, information, and awareness should be distributed about naloxone to increase familiarity and decrease stigma in many communities.
Keywords
Chronic Pain, Pain Management, Naloxone, Opioid Use, Opioid Analgesics, Social Stigma, Health Services Accessibility
Disciplines
Anesthesia and Analgesia | Health and Medical Administration | Health Services Administration | Medicine and Health Sciences | Patient Safety | Pharmaceutical Preparations | Public Health Education and Promotion | Substance Abuse and Addiction | Therapeutics
Document Type
Poster
Included in
Anesthesia and Analgesia Commons, Health and Medical Administration Commons, Health Services Administration Commons, Patient Safety Commons, Pharmaceutical Preparations Commons, Public Health Education and Promotion Commons, Substance Abuse and Addiction Commons, Therapeutics Commons
Barriers in Obtaining a Naloxone Co-prescription for Patients Who Are Prescribed Opioids for Pain Management
As the prevalence of chronic pain rises, the number of patients prescribed opioids is increasing. Consequently, the rate of opioid overdose has increased, becoming a public health concern.For these reasons, the Center for Disease Control and Prevention recommended co-prescribing naloxone, a medicine that reverses the effects of opioid overdose.While this medication can be lifesaving, it is not accessible or available to everyone in need of it. A systematic review of existing literature pertaining to the barriers in patients receiving naloxone was conducted to evaluate the major obstacles in patients receiving a naloxone co-prescription. The results show that the major deterrents include financial cost, geographic location, education, and stigma. Based on these findings, it is recommended that more trainings, information, and awareness should be distributed about naloxone to increase familiarity and decrease stigma in many communities.